WQ96662 (e) Wedi’i gyflwyno ar 17/06/2025

Pa asesiad sydd wedi'i wneud o fanteision posibl defnyddio sganiau CT dos isel yn ystod unrhyw raglen sgrinio ar gyfer canser yr ysgyfaint yn y dyfodol er mwyn dod o hyd i achosion o glefyd rhwystrol cronig yr ysgyfaint lle nad yw'r unigolyn wedi cael diagnosis eto?

Wedi'i ateb gan Ysgrifennydd y Cabinet dros Iechyd a Gofal Cymdeithasol | Wedi'i ateb ar 24/06/2025

The Welsh Government follows the independent, expert advice of the UK National Screening Committee which does not currently recommend screening for COPD.
The Welsh Government expects health boards to deliver spirometry and fractional exhaled nitric oxide (FeNO) testing in line with clinical standards and National Institute for Health and Care Excellence guidelines. We have emphasised the importance of community-based access to spirometry in the Quality Statement for Respiratory Disease. NHS Performance and Improvement is developing new service pathways for new presentations of breathlessness, which are likely to support better community-based provision of spirometry and FeNO.